Increasing vancomycin susceptibility in vancomycin resistant enterococci by vanH promoter and ddl transformation

Journal of Infection

Volumn 48, Issue 4, 2004, Pages 314-319

  Choi, Jun Yong ^a   Chang, Kyung Hee ^a   Lee, Kkot Sil ^a   Song, Young Goo ^a   Kim, June Myung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Bacteria; Enterococcus; Transformation; Vancomycin; Vancomycin resistance

Indexed keywords

PLASMID DNA; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; ELECTROPORATION; ENTEROCOCCUS FAECALIS; GENE CONSTRUCT; GENE EXPRESSION; GENETIC CODE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1942505921     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2003.10.017     Document Type: Article

References (25)

1. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175:117-127.
2. Courvalin P. Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother 1990;34:2291-2296.
3. Rowe PM. Preparing for battle against vancomycin resistance (News). Lancet 1996;347:252.
4. Lecklercq R, Derlot E, Duval J, Courvalin P. Plasmid mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1998;319:157-161.
5. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin resistant enterococci (letter). Lancet 1988;1:57-58.
6. Kim JM, Song YG. Vancomycin resistant enterococcal infections in Korea. Yonsei Med J 1998;39:562-568.
7. Park JW, Kim YR, Shin WS, Kang MW, Han KJ, Shim SI. Susceptibility tests of vancomycin resistant enterococci. Korean J Infect Dis 1992;24:133-137.
8. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000;406:775-781.
9. Walsh C, Fisher SL, Park IS, Prahald M, Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 1996;3:21-28.
10. Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh C. Molecular basis for vancomycin resistance in Enterococcus faecium BM 4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 1991;30: 10408-10415.
11. Torres Viera C, Tsiodras S, Gold HS, et al. Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer. Antimicrob Agents Chemother 2001;45:973-975.
12. Arthur M, Molinas C, Courvalin P. The VanS-VanR two component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1992;174:2582-2591.
13. Arthur M, Depardieu F, Courvalin P. Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococci. Microbiology 1999;145: 1849-1858.
14. Holman T, Wu Z, Wanner B, Walsh C. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. Biochemistry 1994;33:4625-4631.
15. Arthur M, Depardieu F, Gerbaud G, Galimand M, Leclercq R, Courvalin P. The VanS sensor negatively controls VanR mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J Bacteriol 1997;179:97-106.
16. Steven MO, Denneth HM, Antone AM. In: Mandell GL, Bennett JE, Dolin R,, editors, 5th ed. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, vol. 1. Philadelphia: Churchill Livingstone; 2000. p. 236-253.
17. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350:1670-1673.
18. Inouye R, Gillis J, Hammer SM. Combination genetic pharmacological therapy for the treatment of drug resistant and susceptible HIV-1. Antivir Ther 1999;4(Suppl 1):121.
19. Weiss B, Davidkova G, Zhou LW, Antisense RNA. gene therapy for studying and modulating biological processes. Cell Mol Life Sci 1999;55:334-358.
20. Sambrook J, Russell DW, editors. Molecular cloning a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 2001.
21. Mercola D, Cohen JS. Antisense approaches to cancer gene therapy. Cancer Gene Ther 1995;2:47-59.
22. Walch C. Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem 1989;264: 2392-2396.
23. Evers S, Casadewall B, Charles M, Dutka-Malen S, Galimand M, Courvalin P. Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes. J Mol Evol 1996;42:706-712.
24. Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989;8:943-950.
25. Evers S, Reynolds PE, Courvalin P. Sequence of the vanB and ddl genes encoding D-alanine: D-lactate and D-alanine:D-alanine ligases in vancomycin resistant Enterococcus faecalis V583. Gene 1994;140:87-102.